Cleared Traditional

INSPIRON MANIFOLD (DOUBLE) (K772294) - FDA 510(k) Clearance

Class II Anesthesiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K772294 · C.R. Bard, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1978
Decision
35d
Days
Class 2
Risk

K772294 is an FDA 510(k) clearance for the INSPIRON MANIFOLD (DOUBLE). Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by C.R. Bard, Inc. (Mchenry, US). The FDA issued a Cleared decision on January 17, 1978 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all C.R. Bard, Inc. devices

Submission Details

510(k) Number K772294 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 1977
Decision Date January 17, 1978
Days to Decision 35 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
105d faster than avg
Panel avg: 140d · This submission: 35d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 75
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K772294.
2C7153 NEBULIZER CAP
K780406 · Travenol Laboratories, S.A. · Apr 1978
NEBULIZER HEATER
K780456 · Travenol Laboratories, S.A. · Apr 1978
NEBULIZER, DISP, 2D0815
K780119 · Travenol Laboratories, S.A. · Apr 1978
INSPIRON MANIFOLD (SINGLE)
K772295 · C.R. Bard, Inc. · Jan 1978
INSPIRON MANIFOLD
K772296 · C.R. Bard, Inc. · Jan 1978
NEBULIZER SET-2C7105
K772222 · Travenol Laboratories, S.A. · Dec 1977